Global NSAID API Market Growth 2025-2031
The global NSAID API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
LP Information, Inc. (LPI) ' newest research report, the “NSAID API Industry Forecast” looks at past sales and reviews total world NSAID API sales in 2024, providing a comprehensive analysis by region and market sector of projected NSAID API sales for 2025 through 2031. With NSAID API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAID API industry.
This Insight Report provides a comprehensive analysis of the global NSAID API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NSAID API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSAID API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAID API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAID API.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAID API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global NSAID API market?
What factors are driving NSAID API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NSAID API market opportunities vary by end market size?
How does NSAID API break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
LP Information, Inc. (LPI) ' newest research report, the “NSAID API Industry Forecast” looks at past sales and reviews total world NSAID API sales in 2024, providing a comprehensive analysis by region and market sector of projected NSAID API sales for 2025 through 2031. With NSAID API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAID API industry.
This Insight Report provides a comprehensive analysis of the global NSAID API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NSAID API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSAID API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAID API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAID API.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAID API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Paracetamol
- Ibuprofen
- Aspirin
- Naproxen
- Others
- Captive Manufacturing
- Contract Manufacturing
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Pfizer
- Boehringer Ingelheim
- Teva Pharmaceutical
- BASF
- Hospira
- Lonza Group
- Mylan
- Aurobindo Pharma
- Cambrex
- Dr. Reddy's Laboratories
- Actavis
- Wuxi Apptec
- Zhejiang NHU
What is the 10-year outlook for the global NSAID API market?
What factors are driving NSAID API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NSAID API market opportunities vary by end market size?
How does NSAID API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NSAID API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NSAID API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NSAID API by Country/Region, 2020, 2024 & 2031
2.2 NSAID API Segment by Type
2.2.1 Paracetamol
2.2.2 Ibuprofen
2.2.3 Aspirin
2.2.4 Naproxen
2.2.5 Others
2.3 NSAID API Sales by Type
2.3.1 Global NSAID API Sales Market Share by Type (2020-2025)
2.3.2 Global NSAID API Revenue and Market Share by Type (2020-2025)
2.3.3 Global NSAID API Sale Price by Type (2020-2025)
2.4 NSAID API Segment by Application
2.4.1 Captive Manufacturing
2.4.2 Contract Manufacturing
2.5 NSAID API Sales by Application
2.5.1 Global NSAID API Sale Market Share by Application (2020-2025)
2.5.2 Global NSAID API Revenue and Market Share by Application (2020-2025)
2.5.3 Global NSAID API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global NSAID API Breakdown Data by Company
3.1.1 Global NSAID API Annual Sales by Company (2020-2025)
3.1.2 Global NSAID API Sales Market Share by Company (2020-2025)
3.2 Global NSAID API Annual Revenue by Company (2020-2025)
3.2.1 Global NSAID API Revenue by Company (2020-2025)
3.2.2 Global NSAID API Revenue Market Share by Company (2020-2025)
3.3 Global NSAID API Sale Price by Company
3.4 Key Manufacturers NSAID API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAID API Product Location Distribution
3.4.2 Players NSAID API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NSAID API BY GEOGRAPHIC REGION
4.1 World Historic NSAID API Market Size by Geographic Region (2020-2025)
4.1.1 Global NSAID API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NSAID API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NSAID API Market Size by Country/Region (2020-2025)
4.2.1 Global NSAID API Annual Sales by Country/Region (2020-2025)
4.2.2 Global NSAID API Annual Revenue by Country/Region (2020-2025)
4.3 Americas NSAID API Sales Growth
4.4 APAC NSAID API Sales Growth
4.5 Europe NSAID API Sales Growth
4.6 Middle East & Africa NSAID API Sales Growth
5 AMERICAS
5.1 Americas NSAID API Sales by Country
5.1.1 Americas NSAID API Sales by Country (2020-2025)
5.1.2 Americas NSAID API Revenue by Country (2020-2025)
5.2 Americas NSAID API Sales by Type (2020-2025)
5.3 Americas NSAID API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAID API Sales by Region
6.1.1 APAC NSAID API Sales by Region (2020-2025)
6.1.2 APAC NSAID API Revenue by Region (2020-2025)
6.2 APAC NSAID API Sales by Type (2020-2025)
6.3 APAC NSAID API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NSAID API by Country
7.1.1 Europe NSAID API Sales by Country (2020-2025)
7.1.2 Europe NSAID API Revenue by Country (2020-2025)
7.2 Europe NSAID API Sales by Type (2020-2025)
7.3 Europe NSAID API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NSAID API by Country
8.1.1 Middle East & Africa NSAID API Sales by Country (2020-2025)
8.1.2 Middle East & Africa NSAID API Revenue by Country (2020-2025)
8.2 Middle East & Africa NSAID API Sales by Type (2020-2025)
8.3 Middle East & Africa NSAID API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAID API
10.3 Manufacturing Process Analysis of NSAID API
10.4 Industry Chain Structure of NSAID API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAID API Distributors
11.3 NSAID API Customer
12 WORLD FORECAST REVIEW FOR NSAID API BY GEOGRAPHIC REGION
12.1 Global NSAID API Market Size Forecast by Region
12.1.1 Global NSAID API Forecast by Region (2026-2031)
12.1.2 Global NSAID API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NSAID API Forecast by Type (2026-2031)
12.7 Global NSAID API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis NSAID API Product Portfolios and Specifications
13.1.3 Novartis NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer NSAID API Product Portfolios and Specifications
13.2.3 Pfizer NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim NSAID API Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Information
13.4.2 Teva Pharmaceutical NSAID API Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Pharmaceutical Main Business Overview
13.4.5 Teva Pharmaceutical Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF NSAID API Product Portfolios and Specifications
13.5.3 BASF NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira NSAID API Product Portfolios and Specifications
13.6.3 Hospira NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Lonza Group
13.7.1 Lonza Group Company Information
13.7.2 Lonza Group NSAID API Product Portfolios and Specifications
13.7.3 Lonza Group NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lonza Group Main Business Overview
13.7.5 Lonza Group Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan NSAID API Product Portfolios and Specifications
13.8.3 Mylan NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma NSAID API Product Portfolios and Specifications
13.9.3 Aurobindo Pharma NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Cambrex
13.10.1 Cambrex Company Information
13.10.2 Cambrex NSAID API Product Portfolios and Specifications
13.10.3 Cambrex NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cambrex Main Business Overview
13.10.5 Cambrex Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories NSAID API Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Actavis
13.12.1 Actavis Company Information
13.12.2 Actavis NSAID API Product Portfolios and Specifications
13.12.3 Actavis NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Actavis Main Business Overview
13.12.5 Actavis Latest Developments
13.13 Wuxi Apptec
13.13.1 Wuxi Apptec Company Information
13.13.2 Wuxi Apptec NSAID API Product Portfolios and Specifications
13.13.3 Wuxi Apptec NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuxi Apptec Main Business Overview
13.13.5 Wuxi Apptec Latest Developments
13.14 Zhejiang NHU
13.14.1 Zhejiang NHU Company Information
13.14.2 Zhejiang NHU NSAID API Product Portfolios and Specifications
13.14.3 Zhejiang NHU NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang NHU Main Business Overview
13.14.5 Zhejiang NHU Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NSAID API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NSAID API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NSAID API by Country/Region, 2020, 2024 & 2031
2.2 NSAID API Segment by Type
2.2.1 Paracetamol
2.2.2 Ibuprofen
2.2.3 Aspirin
2.2.4 Naproxen
2.2.5 Others
2.3 NSAID API Sales by Type
2.3.1 Global NSAID API Sales Market Share by Type (2020-2025)
2.3.2 Global NSAID API Revenue and Market Share by Type (2020-2025)
2.3.3 Global NSAID API Sale Price by Type (2020-2025)
2.4 NSAID API Segment by Application
2.4.1 Captive Manufacturing
2.4.2 Contract Manufacturing
2.5 NSAID API Sales by Application
2.5.1 Global NSAID API Sale Market Share by Application (2020-2025)
2.5.2 Global NSAID API Revenue and Market Share by Application (2020-2025)
2.5.3 Global NSAID API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global NSAID API Breakdown Data by Company
3.1.1 Global NSAID API Annual Sales by Company (2020-2025)
3.1.2 Global NSAID API Sales Market Share by Company (2020-2025)
3.2 Global NSAID API Annual Revenue by Company (2020-2025)
3.2.1 Global NSAID API Revenue by Company (2020-2025)
3.2.2 Global NSAID API Revenue Market Share by Company (2020-2025)
3.3 Global NSAID API Sale Price by Company
3.4 Key Manufacturers NSAID API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAID API Product Location Distribution
3.4.2 Players NSAID API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NSAID API BY GEOGRAPHIC REGION
4.1 World Historic NSAID API Market Size by Geographic Region (2020-2025)
4.1.1 Global NSAID API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NSAID API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NSAID API Market Size by Country/Region (2020-2025)
4.2.1 Global NSAID API Annual Sales by Country/Region (2020-2025)
4.2.2 Global NSAID API Annual Revenue by Country/Region (2020-2025)
4.3 Americas NSAID API Sales Growth
4.4 APAC NSAID API Sales Growth
4.5 Europe NSAID API Sales Growth
4.6 Middle East & Africa NSAID API Sales Growth
5 AMERICAS
5.1 Americas NSAID API Sales by Country
5.1.1 Americas NSAID API Sales by Country (2020-2025)
5.1.2 Americas NSAID API Revenue by Country (2020-2025)
5.2 Americas NSAID API Sales by Type (2020-2025)
5.3 Americas NSAID API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAID API Sales by Region
6.1.1 APAC NSAID API Sales by Region (2020-2025)
6.1.2 APAC NSAID API Revenue by Region (2020-2025)
6.2 APAC NSAID API Sales by Type (2020-2025)
6.3 APAC NSAID API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NSAID API by Country
7.1.1 Europe NSAID API Sales by Country (2020-2025)
7.1.2 Europe NSAID API Revenue by Country (2020-2025)
7.2 Europe NSAID API Sales by Type (2020-2025)
7.3 Europe NSAID API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NSAID API by Country
8.1.1 Middle East & Africa NSAID API Sales by Country (2020-2025)
8.1.2 Middle East & Africa NSAID API Revenue by Country (2020-2025)
8.2 Middle East & Africa NSAID API Sales by Type (2020-2025)
8.3 Middle East & Africa NSAID API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAID API
10.3 Manufacturing Process Analysis of NSAID API
10.4 Industry Chain Structure of NSAID API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAID API Distributors
11.3 NSAID API Customer
12 WORLD FORECAST REVIEW FOR NSAID API BY GEOGRAPHIC REGION
12.1 Global NSAID API Market Size Forecast by Region
12.1.1 Global NSAID API Forecast by Region (2026-2031)
12.1.2 Global NSAID API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NSAID API Forecast by Type (2026-2031)
12.7 Global NSAID API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis NSAID API Product Portfolios and Specifications
13.1.3 Novartis NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer NSAID API Product Portfolios and Specifications
13.2.3 Pfizer NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim NSAID API Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Information
13.4.2 Teva Pharmaceutical NSAID API Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Pharmaceutical Main Business Overview
13.4.5 Teva Pharmaceutical Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF NSAID API Product Portfolios and Specifications
13.5.3 BASF NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira NSAID API Product Portfolios and Specifications
13.6.3 Hospira NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Lonza Group
13.7.1 Lonza Group Company Information
13.7.2 Lonza Group NSAID API Product Portfolios and Specifications
13.7.3 Lonza Group NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lonza Group Main Business Overview
13.7.5 Lonza Group Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan NSAID API Product Portfolios and Specifications
13.8.3 Mylan NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma NSAID API Product Portfolios and Specifications
13.9.3 Aurobindo Pharma NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Cambrex
13.10.1 Cambrex Company Information
13.10.2 Cambrex NSAID API Product Portfolios and Specifications
13.10.3 Cambrex NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cambrex Main Business Overview
13.10.5 Cambrex Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories NSAID API Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Actavis
13.12.1 Actavis Company Information
13.12.2 Actavis NSAID API Product Portfolios and Specifications
13.12.3 Actavis NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Actavis Main Business Overview
13.12.5 Actavis Latest Developments
13.13 Wuxi Apptec
13.13.1 Wuxi Apptec Company Information
13.13.2 Wuxi Apptec NSAID API Product Portfolios and Specifications
13.13.3 Wuxi Apptec NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuxi Apptec Main Business Overview
13.13.5 Wuxi Apptec Latest Developments
13.14 Zhejiang NHU
13.14.1 Zhejiang NHU Company Information
13.14.2 Zhejiang NHU NSAID API Product Portfolios and Specifications
13.14.3 Zhejiang NHU NSAID API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang NHU Main Business Overview
13.14.5 Zhejiang NHU Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NSAID API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NSAID API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Paracetamol
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Aspirin
Table 6. Major Players of Naproxen
Table 7. Major Players of Others
Table 8. Global NSAID API Sales by Type (2020-2025) & (K MT)
Table 9. Global NSAID API Sales Market Share by Type (2020-2025)
Table 10. Global NSAID API Revenue by Type (2020-2025) & ($ million)
Table 11. Global NSAID API Revenue Market Share by Type (2020-2025)
Table 12. Global NSAID API Sale Price by Type (2020-2025) & (USD/MT)
Table 13. Global NSAID API Sale by Application (2020-2025) & (K MT)
Table 14. Global NSAID API Sale Market Share by Application (2020-2025)
Table 15. Global NSAID API Revenue by Application (2020-2025) & ($ million)
Table 16. Global NSAID API Revenue Market Share by Application (2020-2025)
Table 17. Global NSAID API Sale Price by Application (2020-2025) & (USD/MT)
Table 18. Global NSAID API Sales by Company (2020-2025) & (K MT)
Table 19. Global NSAID API Sales Market Share by Company (2020-2025)
Table 20. Global NSAID API Revenue by Company (2020-2025) & ($ millions)
Table 21. Global NSAID API Revenue Market Share by Company (2020-2025)
Table 22. Global NSAID API Sale Price by Company (2020-2025) & (USD/MT)
Table 23. Key Manufacturers NSAID API Producing Area Distribution and Sales Area
Table 24. Players NSAID API Products Offered
Table 25. NSAID API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global NSAID API Sales by Geographic Region (2020-2025) & (K MT)
Table 29. Global NSAID API Sales Market Share Geographic Region (2020-2025)
Table 30. Global NSAID API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global NSAID API Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global NSAID API Sales by Country/Region (2020-2025) & (K MT)
Table 33. Global NSAID API Sales Market Share by Country/Region (2020-2025)
Table 34. Global NSAID API Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global NSAID API Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas NSAID API Sales by Country (2020-2025) & (K MT)
Table 37. Americas NSAID API Sales Market Share by Country (2020-2025)
Table 38. Americas NSAID API Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas NSAID API Sales by Type (2020-2025) & (K MT)
Table 40. Americas NSAID API Sales by Application (2020-2025) & (K MT)
Table 41. APAC NSAID API Sales by Region (2020-2025) & (K MT)
Table 42. APAC NSAID API Sales Market Share by Region (2020-2025)
Table 43. APAC NSAID API Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC NSAID API Sales by Type (2020-2025) & (K MT)
Table 45. APAC NSAID API Sales by Application (2020-2025) & (K MT)
Table 46. Europe NSAID API Sales by Country (2020-2025) & (K MT)
Table 47. Europe NSAID API Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe NSAID API Sales by Type (2020-2025) & (K MT)
Table 49. Europe NSAID API Sales by Application (2020-2025) & (K MT)
Table 50. Middle East & Africa NSAID API Sales by Country (2020-2025) & (K MT)
Table 51. Middle East & Africa NSAID API Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa NSAID API Sales by Type (2020-2025) & (K MT)
Table 53. Middle East & Africa NSAID API Sales by Application (2020-2025) & (K MT)
Table 54. Key Market Drivers & Growth Opportunities of NSAID API
Table 55. Key Market Challenges & Risks of NSAID API
Table 56. Key Industry Trends of NSAID API
Table 57. NSAID API Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. NSAID API Distributors List
Table 60. NSAID API Customer List
Table 61. Global NSAID API Sales Forecast by Region (2026-2031) & (K MT)
Table 62. Global NSAID API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 64. Americas NSAID API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC NSAID API Sales Forecast by Region (2026-2031) & (K MT)
Table 66. APAC NSAID API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Europe NSAID API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 70. Middle East & Africa NSAID API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global NSAID API Sales Forecast by Type (2026-2031) & (K MT)
Table 72. Global NSAID API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global NSAID API Sales Forecast by Application (2026-2031) & (K MT)
Table 74. Global NSAID API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Novartis Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 76. Novartis NSAID API Product Portfolios and Specifications
Table 77. Novartis NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Pfizer Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer NSAID API Product Portfolios and Specifications
Table 82. Pfizer NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Boehringer Ingelheim Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 86. Boehringer Ingelheim NSAID API Product Portfolios and Specifications
Table 87. Boehringer Ingelheim NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Latest Developments
Table 90. Teva Pharmaceutical Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Pharmaceutical NSAID API Product Portfolios and Specifications
Table 92. Teva Pharmaceutical NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Main Business
Table 94. Teva Pharmaceutical Latest Developments
Table 95. BASF Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 96. BASF NSAID API Product Portfolios and Specifications
Table 97. BASF NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. BASF Main Business
Table 99. BASF Latest Developments
Table 100. Hospira Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 101. Hospira NSAID API Product Portfolios and Specifications
Table 102. Hospira NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Hospira Main Business
Table 104. Hospira Latest Developments
Table 105. Lonza Group Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 106. Lonza Group NSAID API Product Portfolios and Specifications
Table 107. Lonza Group NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Lonza Group Main Business
Table 109. Lonza Group Latest Developments
Table 110. Mylan Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 111. Mylan NSAID API Product Portfolios and Specifications
Table 112. Mylan NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Mylan Main Business
Table 114. Mylan Latest Developments
Table 115. Aurobindo Pharma Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 116. Aurobindo Pharma NSAID API Product Portfolios and Specifications
Table 117. Aurobindo Pharma NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Main Business
Table 119. Aurobindo Pharma Latest Developments
Table 120. Cambrex Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 121. Cambrex NSAID API Product Portfolios and Specifications
Table 122. Cambrex NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Cambrex Main Business
Table 124. Cambrex Latest Developments
Table 125. Dr. Reddy's Laboratories Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 126. Dr. Reddy's Laboratories NSAID API Product Portfolios and Specifications
Table 127. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Dr. Reddy's Laboratories Main Business
Table 129. Dr. Reddy's Laboratories Latest Developments
Table 130. Actavis Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 131. Actavis NSAID API Product Portfolios and Specifications
Table 132. Actavis NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Actavis Main Business
Table 134. Actavis Latest Developments
Table 135. Wuxi Apptec Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuxi Apptec NSAID API Product Portfolios and Specifications
Table 137. Wuxi Apptec NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Wuxi Apptec Main Business
Table 139. Wuxi Apptec Latest Developments
Table 140. Zhejiang NHU Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 141. Zhejiang NHU NSAID API Product Portfolios and Specifications
Table 142. Zhejiang NHU NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Zhejiang NHU Main Business
Table 144. Zhejiang NHU Latest Developments
Table 1. NSAID API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NSAID API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Paracetamol
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Aspirin
Table 6. Major Players of Naproxen
Table 7. Major Players of Others
Table 8. Global NSAID API Sales by Type (2020-2025) & (K MT)
Table 9. Global NSAID API Sales Market Share by Type (2020-2025)
Table 10. Global NSAID API Revenue by Type (2020-2025) & ($ million)
Table 11. Global NSAID API Revenue Market Share by Type (2020-2025)
Table 12. Global NSAID API Sale Price by Type (2020-2025) & (USD/MT)
Table 13. Global NSAID API Sale by Application (2020-2025) & (K MT)
Table 14. Global NSAID API Sale Market Share by Application (2020-2025)
Table 15. Global NSAID API Revenue by Application (2020-2025) & ($ million)
Table 16. Global NSAID API Revenue Market Share by Application (2020-2025)
Table 17. Global NSAID API Sale Price by Application (2020-2025) & (USD/MT)
Table 18. Global NSAID API Sales by Company (2020-2025) & (K MT)
Table 19. Global NSAID API Sales Market Share by Company (2020-2025)
Table 20. Global NSAID API Revenue by Company (2020-2025) & ($ millions)
Table 21. Global NSAID API Revenue Market Share by Company (2020-2025)
Table 22. Global NSAID API Sale Price by Company (2020-2025) & (USD/MT)
Table 23. Key Manufacturers NSAID API Producing Area Distribution and Sales Area
Table 24. Players NSAID API Products Offered
Table 25. NSAID API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global NSAID API Sales by Geographic Region (2020-2025) & (K MT)
Table 29. Global NSAID API Sales Market Share Geographic Region (2020-2025)
Table 30. Global NSAID API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global NSAID API Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global NSAID API Sales by Country/Region (2020-2025) & (K MT)
Table 33. Global NSAID API Sales Market Share by Country/Region (2020-2025)
Table 34. Global NSAID API Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global NSAID API Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas NSAID API Sales by Country (2020-2025) & (K MT)
Table 37. Americas NSAID API Sales Market Share by Country (2020-2025)
Table 38. Americas NSAID API Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas NSAID API Sales by Type (2020-2025) & (K MT)
Table 40. Americas NSAID API Sales by Application (2020-2025) & (K MT)
Table 41. APAC NSAID API Sales by Region (2020-2025) & (K MT)
Table 42. APAC NSAID API Sales Market Share by Region (2020-2025)
Table 43. APAC NSAID API Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC NSAID API Sales by Type (2020-2025) & (K MT)
Table 45. APAC NSAID API Sales by Application (2020-2025) & (K MT)
Table 46. Europe NSAID API Sales by Country (2020-2025) & (K MT)
Table 47. Europe NSAID API Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe NSAID API Sales by Type (2020-2025) & (K MT)
Table 49. Europe NSAID API Sales by Application (2020-2025) & (K MT)
Table 50. Middle East & Africa NSAID API Sales by Country (2020-2025) & (K MT)
Table 51. Middle East & Africa NSAID API Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa NSAID API Sales by Type (2020-2025) & (K MT)
Table 53. Middle East & Africa NSAID API Sales by Application (2020-2025) & (K MT)
Table 54. Key Market Drivers & Growth Opportunities of NSAID API
Table 55. Key Market Challenges & Risks of NSAID API
Table 56. Key Industry Trends of NSAID API
Table 57. NSAID API Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. NSAID API Distributors List
Table 60. NSAID API Customer List
Table 61. Global NSAID API Sales Forecast by Region (2026-2031) & (K MT)
Table 62. Global NSAID API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 64. Americas NSAID API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC NSAID API Sales Forecast by Region (2026-2031) & (K MT)
Table 66. APAC NSAID API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Europe NSAID API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa NSAID API Sales Forecast by Country (2026-2031) & (K MT)
Table 70. Middle East & Africa NSAID API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global NSAID API Sales Forecast by Type (2026-2031) & (K MT)
Table 72. Global NSAID API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global NSAID API Sales Forecast by Application (2026-2031) & (K MT)
Table 74. Global NSAID API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Novartis Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 76. Novartis NSAID API Product Portfolios and Specifications
Table 77. Novartis NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Pfizer Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer NSAID API Product Portfolios and Specifications
Table 82. Pfizer NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Boehringer Ingelheim Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 86. Boehringer Ingelheim NSAID API Product Portfolios and Specifications
Table 87. Boehringer Ingelheim NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Latest Developments
Table 90. Teva Pharmaceutical Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Pharmaceutical NSAID API Product Portfolios and Specifications
Table 92. Teva Pharmaceutical NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Main Business
Table 94. Teva Pharmaceutical Latest Developments
Table 95. BASF Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 96. BASF NSAID API Product Portfolios and Specifications
Table 97. BASF NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. BASF Main Business
Table 99. BASF Latest Developments
Table 100. Hospira Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 101. Hospira NSAID API Product Portfolios and Specifications
Table 102. Hospira NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Hospira Main Business
Table 104. Hospira Latest Developments
Table 105. Lonza Group Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 106. Lonza Group NSAID API Product Portfolios and Specifications
Table 107. Lonza Group NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Lonza Group Main Business
Table 109. Lonza Group Latest Developments
Table 110. Mylan Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 111. Mylan NSAID API Product Portfolios and Specifications
Table 112. Mylan NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Mylan Main Business
Table 114. Mylan Latest Developments
Table 115. Aurobindo Pharma Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 116. Aurobindo Pharma NSAID API Product Portfolios and Specifications
Table 117. Aurobindo Pharma NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Main Business
Table 119. Aurobindo Pharma Latest Developments
Table 120. Cambrex Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 121. Cambrex NSAID API Product Portfolios and Specifications
Table 122. Cambrex NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Cambrex Main Business
Table 124. Cambrex Latest Developments
Table 125. Dr. Reddy's Laboratories Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 126. Dr. Reddy's Laboratories NSAID API Product Portfolios and Specifications
Table 127. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Dr. Reddy's Laboratories Main Business
Table 129. Dr. Reddy's Laboratories Latest Developments
Table 130. Actavis Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 131. Actavis NSAID API Product Portfolios and Specifications
Table 132. Actavis NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Actavis Main Business
Table 134. Actavis Latest Developments
Table 135. Wuxi Apptec Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuxi Apptec NSAID API Product Portfolios and Specifications
Table 137. Wuxi Apptec NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Wuxi Apptec Main Business
Table 139. Wuxi Apptec Latest Developments
Table 140. Zhejiang NHU Basic Information, NSAID API Manufacturing Base, Sales Area and Its Competitors
Table 141. Zhejiang NHU NSAID API Product Portfolios and Specifications
Table 142. Zhejiang NHU NSAID API Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Zhejiang NHU Main Business
Table 144. Zhejiang NHU Latest Developments
LIST OF FIGURES
Figure 1. Picture of NSAID API
Figure 2. NSAID API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAID API Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global NSAID API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NSAID API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NSAID API Sales Market Share by Country/Region (2024)
Figure 10. NSAID API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Paracetamol
Figure 12. Product Picture of Ibuprofen
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Others
Figure 16. Global NSAID API Sales Market Share by Type in 2025
Figure 17. Global NSAID API Revenue Market Share by Type (2020-2025)
Figure 18. NSAID API Consumed in Captive Manufacturing
Figure 19. Global NSAID API Market: Captive Manufacturing (2020-2025) & (K MT)
Figure 20. NSAID API Consumed in Contract Manufacturing
Figure 21. Global NSAID API Market: Contract Manufacturing (2020-2025) & (K MT)
Figure 22. Global NSAID API Sale Market Share by Application (2024)
Figure 23. Global NSAID API Revenue Market Share by Application in 2025
Figure 24. NSAID API Sales by Company in 2025 (K MT)
Figure 25. Global NSAID API Sales Market Share by Company in 2025
Figure 26. NSAID API Revenue by Company in 2025 ($ millions)
Figure 27. Global NSAID API Revenue Market Share by Company in 2025
Figure 28. Global NSAID API Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global NSAID API Revenue Market Share by Geographic Region in 2025
Figure 30. Americas NSAID API Sales 2020-2025 (K MT)
Figure 31. Americas NSAID API Revenue 2020-2025 ($ millions)
Figure 32. APAC NSAID API Sales 2020-2025 (K MT)
Figure 33. APAC NSAID API Revenue 2020-2025 ($ millions)
Figure 34. Europe NSAID API Sales 2020-2025 (K MT)
Figure 35. Europe NSAID API Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa NSAID API Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa NSAID API Revenue 2020-2025 ($ millions)
Figure 38. Americas NSAID API Sales Market Share by Country in 2025
Figure 39. Americas NSAID API Revenue Market Share by Country (2020-2025)
Figure 40. Americas NSAID API Sales Market Share by Type (2020-2025)
Figure 41. Americas NSAID API Sales Market Share by Application (2020-2025)
Figure 42. United States NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC NSAID API Sales Market Share by Region in 2025
Figure 47. APAC NSAID API Revenue Market Share by Region (2020-2025)
Figure 48. APAC NSAID API Sales Market Share by Type (2020-2025)
Figure 49. APAC NSAID API Sales Market Share by Application (2020-2025)
Figure 50. China NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 54. India NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe NSAID API Sales Market Share by Country in 2025
Figure 58. Europe NSAID API Revenue Market Share by Country (2020-2025)
Figure 59. Europe NSAID API Sales Market Share by Type (2020-2025)
Figure 60. Europe NSAID API Sales Market Share by Application (2020-2025)
Figure 61. Germany NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 62. France NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 63. UK NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa NSAID API Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa NSAID API Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa NSAID API Sales Market Share by Application (2020-2025)
Figure 69. Egypt NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of NSAID API in 2025
Figure 75. Manufacturing Process Analysis of NSAID API
Figure 76. Industry Chain Structure of NSAID API
Figure 77. Channels of Distribution
Figure 78. Global NSAID API Sales Market Forecast by Region (2026-2031)
Figure 79. Global NSAID API Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global NSAID API Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global NSAID API Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global NSAID API Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global NSAID API Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of NSAID API
Figure 2. NSAID API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAID API Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global NSAID API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NSAID API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NSAID API Sales Market Share by Country/Region (2024)
Figure 10. NSAID API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Paracetamol
Figure 12. Product Picture of Ibuprofen
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Others
Figure 16. Global NSAID API Sales Market Share by Type in 2025
Figure 17. Global NSAID API Revenue Market Share by Type (2020-2025)
Figure 18. NSAID API Consumed in Captive Manufacturing
Figure 19. Global NSAID API Market: Captive Manufacturing (2020-2025) & (K MT)
Figure 20. NSAID API Consumed in Contract Manufacturing
Figure 21. Global NSAID API Market: Contract Manufacturing (2020-2025) & (K MT)
Figure 22. Global NSAID API Sale Market Share by Application (2024)
Figure 23. Global NSAID API Revenue Market Share by Application in 2025
Figure 24. NSAID API Sales by Company in 2025 (K MT)
Figure 25. Global NSAID API Sales Market Share by Company in 2025
Figure 26. NSAID API Revenue by Company in 2025 ($ millions)
Figure 27. Global NSAID API Revenue Market Share by Company in 2025
Figure 28. Global NSAID API Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global NSAID API Revenue Market Share by Geographic Region in 2025
Figure 30. Americas NSAID API Sales 2020-2025 (K MT)
Figure 31. Americas NSAID API Revenue 2020-2025 ($ millions)
Figure 32. APAC NSAID API Sales 2020-2025 (K MT)
Figure 33. APAC NSAID API Revenue 2020-2025 ($ millions)
Figure 34. Europe NSAID API Sales 2020-2025 (K MT)
Figure 35. Europe NSAID API Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa NSAID API Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa NSAID API Revenue 2020-2025 ($ millions)
Figure 38. Americas NSAID API Sales Market Share by Country in 2025
Figure 39. Americas NSAID API Revenue Market Share by Country (2020-2025)
Figure 40. Americas NSAID API Sales Market Share by Type (2020-2025)
Figure 41. Americas NSAID API Sales Market Share by Application (2020-2025)
Figure 42. United States NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC NSAID API Sales Market Share by Region in 2025
Figure 47. APAC NSAID API Revenue Market Share by Region (2020-2025)
Figure 48. APAC NSAID API Sales Market Share by Type (2020-2025)
Figure 49. APAC NSAID API Sales Market Share by Application (2020-2025)
Figure 50. China NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 54. India NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe NSAID API Sales Market Share by Country in 2025
Figure 58. Europe NSAID API Revenue Market Share by Country (2020-2025)
Figure 59. Europe NSAID API Sales Market Share by Type (2020-2025)
Figure 60. Europe NSAID API Sales Market Share by Application (2020-2025)
Figure 61. Germany NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 62. France NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 63. UK NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa NSAID API Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa NSAID API Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa NSAID API Sales Market Share by Application (2020-2025)
Figure 69. Egypt NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries NSAID API Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of NSAID API in 2025
Figure 75. Manufacturing Process Analysis of NSAID API
Figure 76. Industry Chain Structure of NSAID API
Figure 77. Channels of Distribution
Figure 78. Global NSAID API Sales Market Forecast by Region (2026-2031)
Figure 79. Global NSAID API Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global NSAID API Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global NSAID API Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global NSAID API Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global NSAID API Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Baryte Market Growth 2025-2031
US$ 3,660.00
December 2025
78 pages
Global Fossil Fuels Flotation Agents Market Growth 2023-2029
US$ 3,660.00
March 2023
120 pages
Global 4-Bromostyrene Market Growth 2023-2029
US$ 3,660.00
January 2023
92 pages
Global Hexahydro-1,3,5-Tris(Hydroxyethyl)-S-Triazine Market Growth 2025-2031
US$ 3,660.00
January 2025
88 pages
Global Synthetic and Bio Emulsion Polymers Market Growth 2024-2030
US$ 3,660.00
March 2024
109 pages
